The Discovery of Estrogen Receptor β

In situ hybridization showing ERβ expression in prostatic epithelium (near left) and ovarian granulosa cells (far left). Below is a notebook page describing the phenotypes of ERβ knockout mice. Credit: IN SITU IMAGES: © 1996 THE NATIONAL ACADEMY OF SCIENCES / NOTEBOOK: COURTESY OF JAN-ǺKE GUSTAFSSON" />In situ hybridization showing ERβ expression in prostatic epithelium (near left) and ovarian granulosa cells (far left). Below is a notebook page describing the phenotyp

Written byBrendan Maher
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The first estrogen receptor was discovered in the late 1950s, a period that Jan-Ǻke Gustafsson refers to as BC (before cloning). Forty years later, he and colleagues were looking for a completely unrelated androgen receptor in the prostate when they stumbled across a nuclear hormone receptor with near-perfect homology to the estrogen receptor's DNA binding region, and 58% homology at the c-terminal domain. "We thought it might be a cloning variant," Gustafsson says, but as soon as they realized it was a novel estrogen receptor, they raced to publish the results.1

Dubbing the original protein ERα and this version ERβ, the group and others found the protein expressed in dozens of tissues, but surprisingly, and fortuitously for some clinical applications, not in endometrial tissue or the pituitary. The original in situ hybridizations from rat prostate and ovarian tissue are shown along with a page from Gustafsson's lab notebook describing the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform